Biogenerics also present an opportunity for the bigger firms like Teva, which have the capability to duplicate larger molecule drugs.
FORBES: Four Sexy Cougar Stocks
David Williams is saddened by U.S. biogenerics policy.
FORBES: Health Wonk Review Review: On Vinson, Ryan, & Gawande
It's a different story with biogenerics.
FORBES: Magazine Article
Biogenerics will be reliable moneymakers, too.
应用推荐
模块上移
模块下移
不移动